Cargando…

Rodent Models of Dilated Cardiomyopathy and Heart Failure for Translational Investigations and Therapeutic Discovery

Even with modern therapy, patients with heart failure only have a 50% five-year survival rate. To improve the development of new therapeutic strategies, preclinical models of disease are needed to properly emulate the human condition. Determining the most appropriate model represents the first key s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ponzoni, Matteo, Coles, John G., Maynes, Jason T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963155/ https://www.ncbi.nlm.nih.gov/pubmed/36834573 http://dx.doi.org/10.3390/ijms24043162

Ejemplares similares

Heart failure in dilated non-ischaemic cardiomyopathy
por: Seferović, Petar M, et al.
Publicado: (2019)

Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy‐tailored prognostic model
por: Dziewięcka, Ewa, et al.
Publicado: (2020)

Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure
por: Halliday, Brian P., et al.
Publicado: (2022)

Immunoadsorption Therapy for Patients with Dilated Cardiomyopathy and Heart Failure
por: Ikeda, Uichi, et al.
Publicado: (2008)

Genetics and genomics of dilated cardiomyopathy and systolic heart failure
por: Tayal, Upasana, et al.
Publicado: (2017)

Pulmonary Artery Banding for Dilated Cardiomyopathy in Children: Returning to the Bench from Bedside
por: Ponzoni, Matteo, et al.
Publicado: (2022)

Investigating Ganglion Cell Complex Thickness in Children with Chronic Heart Failure due to Dilated Cardiomyopathy
por: Rakusiewicz, Klaudia, et al.
Publicado: (2020)

Immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy: a potential therapeutic option*
por: Cavusoglu, Yuksel, et al.
Publicado: (2023)

Survival benefit of ghrelin in the heart failure due to dilated cardiomyopathy
por: Du, Cheng-Kun, et al.
Publicado: (2014)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

Prevalence of Anemia in Children with Congestive Heart Failure due to Dilated Cardiomyopathy
por: Mueller, Goetz Christoph, et al.
Publicado: (2012)

Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression
por: Bogomolovas, Julius, et al.
Publicado: (2015)

Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure
por: Farinha, Inês Teixeira, et al.
Publicado: (2016)

Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure
por: Vignoli, Alessia, et al.
Publicado: (2022)

Usefulness of Running Wheel for Detection of Congestive Heart Failure in Dilated Cardiomyopathy Mouse Model
por: Sugihara, Masami, et al.
Publicado: (2013)

Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy
por: Kozdag, Guliz, et al.
Publicado: (2008)

Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence
por: Gonzalez-Valdes, I., et al.
Publicado: (2015)

Identification of Potential Gene Interactions in Heart Failure Caused by Idiopathic Dilated Cardiomyopathy
por: Huang, Huijuan, et al.
Publicado: (2018)

Immune-inflammatory concept of the pathogenesis of chronic heart failure in dogs with dilated cardiomyopathy
por: Vatnikov, Yu, et al.
Publicado: (2019)

Nemaline myopathy with dilated cardiomyopathy and severe heart failure: A case report
por: Wang, Qian, et al.
Publicado: (2021)

Choroidal thickness changes in children with chronic heart failure due to dilated cardiomyopathy
por: Rakusiewicz, Klaudia, et al.
Publicado: (2021)

Dilated Cardiomyopathy and Systolic Heart Failure in a Female Patient With Danon Disease
por: Stack-Pyle, Taylor J, et al.
Publicado: (2022)

CMRI morphological and functional changes of the heart in myocarditis and dilated cardiomyopathy in acute pediatric heart failure
por: Kharabish, Ahmed E
Publicado: (2016)

The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy
por: Makarewich, Catherine A, et al.
Publicado: (2018)

Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy
por: Halliday, Brian P., et al.
Publicado: (2022)

Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure
por: Garza-Cervantes, J. A., et al.
Publicado: (2020)

Comparison of myocardial mechanical properties in patients with dilated cardiomyopathy with and without acute heart failure
por: Choudhary, Naila, et al.
Publicado: (2014)

Identification of micro-RNA networks in end-stage heart failure because of dilated cardiomyopathy
por: Zhu, Xiaoming, et al.
Publicado: (2013)

Circulating Omentin-1 Levels Are Decreased in Dilated Cardiomyopathy Patients with Overt Heart Failure
por: Huang, Ying, et al.
Publicado: (2016)

The Role of Serum Adiponectin for Outcome Prediction in Patients with Dilated Cardiomyopathy and Advanced Heart Failure
por: Baltrūnienė, Vaida, et al.
Publicado: (2017)

Enhanced heart failure, mortality and renin activation in female mice with experimental dilated cardiomyopathy
por: Tripathi, Ranjana, et al.
Publicado: (2017)

Retraction: Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence
por: Gonzalez-Valdes, I, et al.
Publicado: (2017)

Case 4/2017 - Young Male Marathoner with Heart Failure Due to Dilated Cardiomyopathy
por: Ramirez, Hilda Sara Montero, et al.
Publicado: (2017)

Wilms Tumor with dilated hypertensive cardiomyopathy, acute myocarditis, pulmonary edema, and heart failure
por: Chung, Jae Min, et al.
Publicado: (2020)

Neonatal heart failure and noncompaction/dilated cardiomyopathy from mucopolysaccharidosis. First description in literature
por: Miselli, Francesca, et al.
Publicado: (2021)

Prevalence of Chagas heart disease in dilated cardiomyopathy
por: González-Zambrano, Héctor, et al.
Publicado: (2021)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Characteristics of Blood Metabolic Profile in Coronary Heart Disease, Dilated Cardiomyopathy and Valvular Heart Disease Induced Heart Failure
por: Liu, Chang, et al.
Publicado: (2021)

Transcriptomics and Beyond in Dilated Cardiomyopathy
por: Cowan, Jason R., et al.
Publicado: (2023)

Dilated cardiomyopathy-mediated heart failure induces a unique skeletal muscle myopathy with inflammation
por: Song, Taejeong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pnvd2ena653bvb7ncqthuhuhkv